Little is known about what causes ovarian cancer, and there is no way to detect it early yet. About 75% of the time when ...

Little is known about what causes ovarian cancer, and there is no way to detect it early yet. About 75% of the time when someone is diagnosed with ovarian cancer, it has already progressed to stage 3 ...

The preliminary studies in ovarian carcinoma indicate that serial assessment of tumor metabolism by quantitative and/or semiquantitative PET studies by biologically characterizing the disease ...

New blood tests promise to detect malignancies before they’ve spread. But proving that these tests actually improve outcomes ...

HanchorBio inks licensing pact with Shanghai Henlius Biotech to develop & commercialise HCB101 across Greater China: Taipei, Shanghai Saturday, July 5, 2025, 10:00 Hrs [IST] Hanch ...

Scientists have developed tiny nanocrystal particles made up of isotopes of the elements lanthanum, vanadium, and oxygen for ...

The Ridley-Tree Cancer Center just launched its new High-Risk Breast Clinic in Santa Barbara. The focus of the new clinic is to ...

Ridley-Tree Cancer Center (now part of Sutter Health) has opened its High-Risk Breast Clinic, dedicated to monitoring women at elevated risk for breast ...

TAIPEI and SHANGHAI and SAN FRANCISCO, July 1, 2025 /PRNewswire/ -- HanchorBio Inc. (7827.TWO), a global clinical-stage ...

MP0726, a Radio-DARPin candidate targeting mesothelin (MSLN) and intended for the treatment of ovarian cancer, is nominated for developm ...

Peter Moulding joined a clinical trial for the drug AMP945 not really knowing whether it would help him with deadly stage ...

A new cancer treatment that delivers radiation directly to tumors by targeting two key markers simultaneously has been shown ...